tradingkey.logo
tradingkey.logo
Suchen

KORU Medical Systems Inc

KRMD
Zur Watchlist hinzufügen
4.490USD
+0.090+2.05%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
208.20MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über KORU Medical Systems Inc Unternehmen

KORU Medical Systems, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing patient-centric large volume subcutaneous infusion solutions primarily for the subcutaneous drug delivery market. The Company is focused on its mechanical infusion products, the FREEDOM Infusion Systems (FREEDOM System), which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The Company’s infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.

KORU Medical Systems Inc Informationen

BörsenkürzelKRMD
Name des UnternehmensKORU Medical Systems Inc
IPO-datumOct 27, 1993
CEOTharby (Linda M)
Anzahl der mitarbeiter80
WertpapierartOrdinary Share
GeschäftsjahresendeOct 27
Addresse100 Corporate Drive
StadtMAHWAH
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl07430
Telefon18454692042
Websitehttps://www.korumedical.com/
BörsenkürzelKRMD
IPO-datumOct 27, 1993
CEOTharby (Linda M)

Führungskräfte von KORU Medical Systems Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Linda M. Tharby
Ms. Linda M. Tharby
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.20M
+0.65%
Mr. Adam Kalbermatten
Mr. Adam Kalbermatten
Chief Commercial Officer
Chief Commercial Officer
312.50K
+4.00%
Mr. Christopher (Chris) Pazdan
Mr. Christopher (Chris) Pazdan
Chief Operating Officer
Chief Operating Officer
308.99K
+2.87%
Mr. Shahriar (Shar) Matin
Mr. Shahriar (Shar) Matin
Independent Director
Independent Director
101.14K
+3.53%
Dr. Donna French, Ph.D.
Dr. Donna French, Ph.D.
Independent Director
Independent Director
98.51K
+3.62%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Director
Independent Director
98.16K
+3.64%
Mr. Edward Wholihan
Mr. Edward Wholihan
Director
Director
51.31K
+6.96%
Mr. Joseph M. Manko, Jr., J.D.
Mr. Joseph M. Manko, Jr., J.D.
Independent Director
Independent Director
--
--
Mr. R. John Fletcher
Mr. R. John Fletcher
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Thomas (Tom) Adams
Mr. Thomas (Tom) Adams
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Linda M. Tharby
Ms. Linda M. Tharby
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.20M
+0.65%
Mr. Adam Kalbermatten
Mr. Adam Kalbermatten
Chief Commercial Officer
Chief Commercial Officer
312.50K
+4.00%
Mr. Christopher (Chris) Pazdan
Mr. Christopher (Chris) Pazdan
Chief Operating Officer
Chief Operating Officer
308.99K
+2.87%
Mr. Shahriar (Shar) Matin
Mr. Shahriar (Shar) Matin
Independent Director
Independent Director
101.14K
+3.53%
Dr. Donna French, Ph.D.
Dr. Donna French, Ph.D.
Independent Director
Independent Director
98.51K
+3.62%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Director
Independent Director
98.16K
+3.64%

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von KORU Medical Systems Inc?

Die fünf größten Anteilseigner von KORU Medical Systems Inc sind: Ms. Linda M. Tharby

Wie viele Institutionen halten Anteile an KORU Medical Systems Inc (KRMD)?

Mit Stand vom 2026Q1 halten 188 Institutionen Anteile an KORU Medical Systems Inc, mit einem Gesamtmarktwert von etwa 28.85M, was 62.71% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -129292.00 gestiegen.

Was ist die größte Einnahmequelle von KORU Medical Systems Inc?

Am 2026Q1 erzielte das Geschäft mit Domestic Core für KORU Medical Systems Inc den höchsten Umsatz in Höhe von 27.99M, was 68.06% des Gesamtumsatzes entspricht.